American Society of Nephrology Quiz and Questionnaire 2015: ESRD/RRT

Abstract

The Nephrology Quiz and Questionnaire remains an extremely popular session for attendees of the Annual Kidney Week Meeting of the American Society of Nephrology. During the 2015 meeting, the conference hall was once again overflowing with eager quiz participants. Topics covered by the experts included electrolyte and acid-base disorders, glomerular disease, ESRD and dialysis, and kidney transplantation. Complex cases representing each of these categories together with single best answer questions were prepared and submitted by the panel of experts. Before the meeting, training program directors of nephrology fellowship programs and nephrology fellows in the United States answered the questions through an internet-based questionnaire. During the live session, members of the audience tested their knowledge and judgment on the same series of case-oriented questions in a quiz. The audience compared their answers in real time using a cellphone application containing the answers of the nephrology fellows and training program directors. The results of the online questionnaire were displayed, and then, the quiz answers were discussed. As always, the audience, lecturers, and moderators enjoyed this highly educational session. This article recapitulates the session and reproduces selected content of educational value for the readers of the Clinical Journal of the American Society of Nephrology. Enjoy the clinical cases and expert discussions.

LncRNA H19: a novel player in the regulation of diabetic kidney disease

“…It is estimated that more than 40% of individuals with diabetes worldwide are affected by DKD, which is a leading cause of chronic kidney disease (CKD) and end-stage kidney disease (ESRD) ( 5 ). Moreover, DKD patients with ESRD have an alarmingly high mortality rate ( 6 ), and the therapy typically required for survival is renal replacement therapy (RRT), such as kidney dialysis or transplantation, both of which impose a huge financial burden on individuals and society ( 7 ). Hence, a deeper understanding of the molecular mechanisms underlying DKD is urgently required to assist in the discovery of effective therapeutics that can halt its progression and lower the associated risks.…”